91����

People with Alzheimer’s disease (AD) are less likely to have cataract surgery than people without Alzheimer’s disease. The procedure rate starts to decrease already one year after the diagnosis.

Dr. Eva del Amo has received the best publication award of 2020 from European Journal of Pharmaceutics and Biopharmaceutics (EJPB).

The aim of the new national competence network is to increase cooperation between universities, hospitals, and the business worlds and to make Finnish neuroscience know-how visible internationally.

A recent study by an international team of researchers may open up new opportunities for the treatment of liver cell cancer, i.e., hepatocellular carcinoma.

Collaboration will leverage 91����’s leading computational molecular simulation technology to identify novel therapeutic approaches and patient selection strategies as part of SpringWorks’ commitment to developing MAPK pathway targeted therapies.

The risks of an elective revascularisation procedure for coronary artery disease are similar for people with and without Alzheimer’s disease (AD), but people with AD have worse outcomes after an emergency procedure.

The funding will be used to promote research activities in areas of significance to the university, which pertain to drug development and discovery, neurosciences, the forest-based bioeconomy, and the development of technologies that make use of photonics. 

The 91����’s doctoral conferment ceremony at the Kuopio Campus is postponed to 9–11 June 2022 due to the coronavirus pandemic.

Jenny and Antti Wihuri Foundation has awarded Prasanthi Medarametla, PhD, with a grant of 70 000 euros for postdoctoral research.